Medical News

---

• Short telomere load linked to depressive episode number in BD II patients
• Neurometabolite levels linked to thought disorder in childhood-onset schizophrenia
• Apixaban superior to warfarin for stroke prevention in AF
• PURE study finds secondary prevention use tied to country income
• Colchicine halves rate of recurrent pericarditis
• Oral hypoglycemics do not reduce fenofibrate CV benefit
• Dalcetrapib well tolerated and effective for raising HDL cholesterol
• Apixaban superior to warfarin for stroke prevention in AF
• Mind/body psychological skills intervention could improve IVF outcomes

Short telomere load linked to depressive episode number in BD II patients Posted: 30 Aug 2011 05:00 PM PDT Patients with bipolar II disorder have a significantly higher load of short telomeres than mentally healthy individuals, research shows.

Neurometabolite levels linked to thought disorder in childhood-onset schizophrenia Posted: 30 Aug 2011 05:00 PM PDT Neurometabolite concentrations in brain regions associated with language are correlated with thought disorder severity in young patients with childhood-onset schizophrenia, US research suggests.

Apixaban superior to warfarin for stroke prevention in AF Posted: 29 Aug 2011 05:00 PM PDT The novel anticoagulant apixaban resulted in a significant reduction in the risk for stroke and systemic embolism compared with warfarin in patients with atrial fibrillation, results of ARISTOTLE reveal.

PURE study finds secondary prevention use tied to country income Posted: 29 Aug 2011 05:00 PM PDT Use of secondary prevention drugs is low among cardiovascular patients in the community, especially if they live in low-income countries, show the results of the PURE study.

Colchicine halves rate of recurrent pericarditis Posted: 29 Aug 2011 05:00 PM PDT Addition of colchicine to conventional treatment halves the rate of pericarditis recurrence, show results from the CORP trial.

Oral hypoglycemics do not reduce fenofibrate CV benefit Posted: 29 Aug 2011 05:00 PM PDT Cardiovascular outcomes in Type 2 diabetes patients taking fenofibrate or placebo do not differ according to whether they are taking concomitant metformin or sulfonylurea therapy, research shows.

Dalcetrapib well tolerated and effective for raising HDL cholesterol Posted: 29 Aug 2011 05:00 PM PDT The cholesteryl ester transfer protein inhibitor dalcetrapib increases high-density lipoprotein cholesterol without the accompanying adverse cardiovascular effects seen with torcetrapib, show results from the dal-VESSEL study.

Apixaban superior to warfarin for stroke prevention in AF Posted: 29 Aug 2011 05:00 PM PDT The novel anticoagulant apixaban resulted in a significant reduction in the risk for stroke and systemic embolism compared with warfarin in patients with atrial fibrillation, results of ARISTOTLE reveal.

Mind/body psychological skills intervention could improve IVF outcomes Posted: 01 May 2011 05:00 PM PDT US study results suggest that psychological distress may be detrimental to IVF outcomes.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610